Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Sideroblastic Anemia | Case report

Deferasirox

Drug-induced ileocolitis

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Fuentes-Valenzuela E, et al. Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitis. Gastroenterologia y Hepatologia 47: 380-381, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1016/j.gastrohep.2023.07.002 Fuentes-Valenzuela E, et al. Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitis. Gastroenterologia y Hepatologia 47: 380-381, No. 4, Apr 2024. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​gastrohep.​2023.​07.​002
Metadata
Title
Deferasirox
Drug-induced ileocolitis
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56797-y

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Prilocaine

Case report

Epinephrine

Case report

Pyridostigmine

Case report

Epoprostenol